By Zeba Siddiqui MUMBAI (Reuters) - Indian drugmaker Wockhardt's steps to have the United States lift bans on products from two of its plants are unlikely to approved until next year, its chairman said on Monday after the company posted a heavy fall in quarterly profit. Last year's bans by the U.S. Food and Drug Administration (FDA) over quality control lapses halted exports to the United States and were largely responsible for net profit in the three months to Sept. 31 tumbling 97 percent year on year to 36.3 million rupees ($591,446). ...
via Health News Headlines - Yahoo News http://ift.tt/1DSwRb5
No comments:
Post a Comment